Recent Launches Travere Therapeutics has recently launched new therapies for rare diseases in the U.S., including IgAN medicines. This presents a prime opportunity to engage with healthcare providers and hospitals to offer these innovative treatments.
Investment Partnership Panagora Asset Management has made a significant investment in Travere Therapeutics. This financial backing indicates confidence in the company's growth potential, opening avenues for collaboration with other investors or financial institutions.
Global Licensing Agreements Travere Therapeutics has entered licensing agreements with Renalys Pharma and Pharmaceutical Technology for product development in Asian countries and commercialization in Japan, South Korea, and Southeast Asia. Leveraging these partnerships can lead to international sales expansion and market penetration strategies.
Industry Recognition Travere Therapeutics being recognized in the Debt & Financing category highlights its financial stability and strategic planning. This recognition can be utilized to build credibility and trust with potential partners and investors, potentially creating new sales opportunities.
Competitive Analysis With similar companies like CSL Behring, Sanofi Genzyme, Vertex Pharmaceuticals, and others in the market, Travere Therapeutics can benchmark its revenue, funding, and employee strength to strategize competitive pricing, innovative sales approaches, and differentiation tactics to capture market share effectively.
10K
$1B
9.9K$1B
6.1K$1B
10K$1B
11K$1B
1.5K$100M$1B
36K$1B
15K$1BTravere Therapeutics uses 8 technology products and services including Linkedin Ads, SAS, Font Awesome, and more. Explore Travere Therapeutics's tech stack below.
| Travere Therapeutics Email Formats | Percentage |
| First.Last@travere.com | 90% |
| First@travere.com | 4% |
| Last@travere.com | 3% |
| FirstLast@travere.com | 3% |
Biotechnology ResearchCalifornia, United States201-500 Employees
Our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. #InRareForLife Community Guidelines: https://travere.com/community-guidelines/
Company Overview
Media & News
Funding & FinancialsTravere Therapeutics has raised a total of $200M of funding over 7 rounds. Their latest funding round was raised on Feb 28, 2023 in the amount of $200M.
Travere Therapeutics's revenue is in the range of $10M$50M
Funding & FinancialsTravere Therapeutics has raised a total of $200M of funding over 7 rounds. Their latest funding round was raised on Feb 28, 2023 in the amount of $200M.
Travere Therapeutics's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com